Announcements
To clarify the media report
1.Date of occurrence of the event:2016/08/31 2.Company name: OBI Pharma, Inc. 3.Relationship to the Company (please enter ”head office” or ”affiliatecompany”): N/A 4.Reciprocal shareholding ratios: N/A 5.Name of mass media: …
OBI Pharma Inc. announces the change of VP, Chief Medical Officer
1.Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel(CEO, COO, CMO, CSO, etc.),financial officer, accounting officer, research and development officer, or internal audit officer): VP, Chief Medical Officer …
To clarify the media report
1.Date of occurrence of the event: 2016/07/01 2.Company name: OBI Pharma, Inc. 3.Relationship to the Company (please enter ”head office” or ”affiliatecompany”): The Company head office 4.Reciprocal shareholding ratios: N/A …
Important resolutions of 2016 Annual General Shareholders’ Meeting
1.Date of the shareholders’ meeting: 2016/06/27 2.Important resolutions (1) profit distribution/deficit compensation: Resolution of recognizing the annual deficiency appropriation in the 104th year of the Republic of China. 3.Important resolutions …
The Re-election of Directors at 2016 Annual General Shareholders’ Meeting
1.Date of occurrence of the change:2016/06/27 2.Appointment of or changed personnel (juristic-person director, juristic-person supervisor, independent director, natural-person director or natural-person supervisor):natural-person director, juristic-person director, independent director. 3.Title, name and …
OBI Pharma ‘s 2016 Annual General Meeting has approved to release the newly elected Director from non-competition restriction
1.Date of the shareholders’ meeting resolution:2016/06/27 2.Name and title of the director with permission to engage in competitive conduct: Director Michael Chang (Representative of Yi Tai Fund Co.) Director Tamon …
OBI Pharma, Inc. announces the re-appointment of Mr. Michael Chang as the Chairman of the Company.
1.Date of the board of directors resolution or date of occurrence of the change:2016/06/27 2.Type of personnel (chairman or general manager):Chairman 3.Name and resume of the replaced personnel: Michael Chang, …
The company was invited to participate in the overseas NDR (Non-Deal Roadshow) organized by Credit Suisse, and reported the study results presented in the 2016 ASCO.
1.Date of the investor conference:2016/06/16~2016/06/18 2.Time of the investor conference: 00:00 3.Location of the investor conference: Boston/New York, USA 4.Brief information disclosed in the investor conference: The company was invited …
OBI Pharma, Inc. will attend Cathay Securities’ Conference on June 16th
1.Date of the investor conference:2016/06/16 2.Time of the investor conference:9:55 a.m.(Taiwan Time) 3.Location of the investor conference: 4F., No.3, LN. 39, Sec. 2 Zhongshan N. Rd., Taipei 104, Taiwan (Regent …
To correct the company’s Investor Conference presentation content on June 5 2016
1.Date of occurrence of the event:2016/06/07 2.Company name: OBI Pharma, Inc. 3.Relationship to the Company (please enter ”head office” or”subsidiaries”): The Company head office 4.Reciprocal shareholding ratios: N/A 5.Cause of …